Regulatory Information
OPELLA HEALTHCARE SINGAPORE PTE. LTD.
OPELLA HEALTHCARE SINGAPORE PTE. LTD.
Therapeutic
General Sale List
Formulation Information
CAPSULE, DELAYED RELEASE
**(d) How to take MUCOSOLVAN once-daily prolonged-release capsules** Always take this medicine exactly as described in this package leaflet or exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The recommended dose is: The usual dosage is one prolonged-release capsule (equivalent to 75 mg ambroxol hydrochloride/day) once daily. **Method and duration of treatment** MUCOSOLVAN once-daily prolonged-release capsules can be taken with or without food and should be swallowed whole with sufficient amounts of liquid (e.g., water, tea or fruit juice). You should consult a doctor if your symptoms worsen or if there is no improvement after 4–5 days. Please speak to your doctor or pharmacist if you feel that the effect of MUCOSOLVAN once-daily prolonged-release capsules is too strong or too weak.
ORAL
Medical Information
**(b) What MUCOSOLVAN once-daily prolonged-release capsules are and what they are used for** Mucosolvan is used in conditions where there are a lot of thick secretion or mucus in your air passages. Mucosolvan contains ambroxol hydrochloride, which helps to clear the chest by thinning the mucus in your air passage.
**(c) What you need to know before you take MUCOSOLVAN once-daily prolonged-release capsules** **MUCOSOLVAN once-daily prolonged-release capsules should not be taken:** - If you are hypersensitive (allergic) to the active substance ambroxol hydrochloride or to any of the other ingredients of this medicine listed in Section (a) – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_.
R05CB06
ambroxol
Manufacturer Information
OPELLA HEALTHCARE SINGAPORE PTE. LTD.
Sanofi Winthrop Industrie
Active Ingredients
Documents
Patient Information Leaflets
Mucosolvan 24 Hours Capsule PIL.pdf
Approved: December 30, 2022